Clinical trial
HEROIC (Heparin Requirement in Counterpulsation)
NCT00445211 · Corewell Health East, Other · Terminated
Key facts
| NCT number | NCT00445211 |
|---|---|
| Title | HEROIC (Heparin Requirement in Counterpulsation) |
| Official title | Heparin Requirement in Counterpulsation |
| Acronym | HEROIC |
| Lead sponsor | Corewell Health East, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiogenic Shock |
| Intervention type | Drug, Other |
| Interventions | Heparin, Without Heparin |
| Enrollment | 46 |
| Start date | Jan 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Mar 8, 2007 |
| Last update posted | May 19, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: